Page last updated: 2024-08-21

tetramethylpyrazine and Cancer of the Retina

tetramethylpyrazine has been researched along with Cancer of the Retina in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, S; Chen, X; Ge, J; Han, X; Qiu, J; Wu, C; Wu, N; Wu, Y; Yang, M; Yang, Y; Yu, K; Yu, N; Zhang, J; Zhuang, J	1

Other Studies

1 other study(ies) available for tetramethylpyrazine and Cancer of the Retina

Article	Year
Tetramethylpyrazine downregulates transcription of the CXC receptor 4 (CXCR4) via nuclear respiratory factor‑1 (Nrf‑1) in WERI‑Rb1 retinoblastoma cells. Oncology reports, 2019, Volume: 42, Issue:3 Topics: Animals; Apoptosis; Biomarkers, Tumor; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Nuclear Respiratory Factor 1; Pyrazines; Receptors, CXCR4; Retinal Neoplasms; Retinoblastoma; Transcription, Genetic; Tumor Cells, Cultured; Vasodilator Agents; Xenograft Model Antitumor Assays	2019

Article

Year

Tetramethylpyrazine downregulates transcription of the CXC receptor 4 (CXCR4) via nuclear respiratory factor‑1 (Nrf‑1) in WERI‑Rb1 retinoblastoma cells.

Oncology reports, 2019, Volume: 42, Issue:3

Topics: Animals; Apoptosis; Biomarkers, Tumor; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Nuclear Respiratory Factor 1; Pyrazines; Receptors, CXCR4; Retinal Neoplasms; Retinoblastoma; Transcription, Genetic; Tumor Cells, Cultured; Vasodilator Agents; Xenograft Model Antitumor Assays

2019